Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1144

1.

Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging.

Evans A, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PA, Bick U, Camps Herrero J, Clauser P, Colin C, Cornford E, Fallenberg EM, Fuchsjaeger MH, Gilbert FJ, Helbich TH, Kinkel K, Heywang-Köbrunner SH, Kuhl CK, Mann RM, Martincich L, Panizza P, Pediconi F, Pijnappel RM, Pinker K, Zackrisson S, Forrai G, Sardanelli F; European Society of Breast Imaging (EUSOBI) , with language review by Europa Donna–The European Breast Cancer Coalition.

Insights Imaging. 2018 Aug 9. doi: 10.1007/s13244-018-0636-z. [Epub ahead of print]

PMID:
30094592
2.

T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer.

Fabi A, Alesini D, Valle E, Moscetti L, Caputo R, Caruso M, Carbognin L, Ciccarese M, La Verde N, Arpino G, Cannita K, Paris I, Santini D, Montemurro F, Russillo M, Ferretti G, Filippelli G, Rossello R, Fabbri A, Zambelli A, Leonardi V, D'Ottavio AM, Nisticò C, Stani S, Giampaglia M, Scandurra G, Catania G, Malaguti P, Giannarelli D, Cognetti F.

Breast. 2018 Jul 12;41:137-143. doi: 10.1016/j.breast.2018.07.004. [Epub ahead of print]

PMID:
30092500
3.

Development of a "ready to use" graphical tool based on artificial neural network classification: application for the prediction of late fecal incontinence after prostate cancer radiotherapy.

Carrara M, Massari E, Cicchetti A, Giandini T, Avuzzi B, Palorini F, Stucchi C, Fellin G, Gabriele P, Vavassori V, Esposti CD, Cozzarini C, Pignoli E, Fiorino C, Rancati T, Valdagni R.

Int J Radiat Oncol Biol Phys. 2018 Aug 6. pii: S0360-3016(18)33482-5. doi: 10.1016/j.ijrobp.2018.07.2014. [Epub ahead of print]

PMID:
30092335
4.

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience.

Sbrana A, Biasco E, Paolieri F, Palesandro E, Caserta C, Iacovelli R, Detti B, Santini D, Mosca A, Morelli F, Fornarini G, DE Giorgi U, Masini C, Galli L.

Anticancer Res. 2018 Aug;38(8):4913-4918. doi: 10.21873/anticanres.12807.

PMID:
30061269
5.

A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.

Gadducci A, Grosso F, Scambia G, Raspagliesi F, Colombo N, Grignani G, Casali P, Sanfilippo R, Buonadonna A, Santoro A, Bruzzone M, Artioli G, Lorusso D, Biagioli E, Fossati R, Galli F, Negri E, Rulli E, Torri V, D'Incalci M.

Br J Cancer. 2018 Jul 30. doi: 10.1038/s41416-018-0190-y. [Epub ahead of print]

PMID:
30057406
6.

Bone metastases in biliary cancers: A multicenter retrospective survey.

Santini D, Brandi G, Aprile G, Russano M, Cereda S, Leone F, Lonardi S, Fornaro L, Scartozzi M, Silvestris N, Barni S, Pantano F, Vincenzi B, Palloni A, Frega G, Casagrande M, Ferrari L, Dadduzio V, Intini R, Filippi R, Vasile E, Vivaldi C, Faloppi L, Brunetti O, Reni M, Aglietta M, Tonini G.

J Bone Oncol. 2018 Apr 7;12:33-37. doi: 10.1016/j.jbo.2017.11.006. eCollection 2018 Sep.

7.

Salvage radiation therapy after radical prostatectomy: survival analysis.

Galla A, Maggio A, Delmastro E, Garibaldi E, Gabriele P, Bresciani S, Di Dia A, Stasi M, Gabriele D.

Minerva Urol Nefrol. 2018 Jul 23. doi: 10.23736/S0393-2249.18.03124-7. [Epub ahead of print]

PMID:
30037205
8.

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study.

Galizia D, Milani A, Geuna E, Martinello R, Cagnazzo C, Foresto M, Longo V, Berchialla P, Solinas G, Calori A, Grasso B, Volpone C, Bertola G, Parola G, Tealdi G, Giuliano PL, Ballari AM, Aglietta M, Montemurro F.

Cancer Med. 2018 Jul 20. doi: 10.1002/cam4.1687. [Epub ahead of print]

9.

miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.

Migliore C, Morando E, Ghiso E, Anastasi S, Leoni VP, Apicella M, Cora' D, Sapino A, Pietrantonio F, De Braud F, Columbano A, Segatto O, Giordano S.

EMBO Mol Med. 2018 Jul 18. pii: e8746. doi: 10.15252/emmm.201708746. [Epub ahead of print]

10.

TRIPLETE: a randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer.

Borelli B, Moretto R, Lonardi S, Bonetti A, Antoniotti C, Pietrantonio F, Masi G, Burgio V, Marmorino F, Salvatore L, Rossini D, Zaniboni A, Zucchelli G, Martignetti A, Di Battista M, Pella N, Passardi A, Boccaccino A, Leone F, Colombo C, Granetto C, Vannini F, Marsico VA, Martinelli E, Antonuzzo L, Vitello S, Delliponti L, Boni L, Cremolini C, Falcone A.

ESMO Open. 2018 Jul 9;3(4):e000403. doi: 10.1136/esmoopen-2018-000403. eCollection 2018.

11.

Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: a safe strategy to enhance the graft versus tumor effect.

Circosta P, Vitaggio K, Elia AR, Todorovic M, Sangiolo D, Carnevale-Schianca F, Vallario A, Geuna M, Aglietta M, Cignetti A.

Immunotherapy. 2018 Jul;10(9):753-767. doi: 10.2217/imt-2017-0139.

PMID:
30008257
12.

Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer.

Siravegna G, Lazzari L, Crisafulli G, Sartore-Bianchi A, Mussolin B, Cassingena A, Martino C, Lanman RB, Nagy RJ, Fairclough S, Rospo G, Corti G, Bartolini A, Arcella P, Montone M, Lodi F, Lorenzato A, Vanzati A, Valtorta E, Cappello G, Bertotti A, Lonardi S, Zagonel V, Leone F, Russo M, Balsamo A, Truini M, Di Nicolantonio F, Amatu A, Bonazzina E, Ghezzi S, Regge D, Vanzulli A, Trusolino L, Siena S, Marsoni S, Bardelli A.

Cancer Cell. 2018 Jul 9;34(1):148-162.e7. doi: 10.1016/j.ccell.2018.06.004.

PMID:
29990497
13.

α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis.

Atlante S, Visintin A, Marini E, Savoia M, Dianzani C, Giorgis M, Sürün D, Maione F, Schnütgen F, Farsetti A, Zeiher AM, Bertinaria M, Giraudo E, Spallotta F, Cencioni C, Gaetano C.

Cell Death Dis. 2018 Jul 9;9(7):756. doi: 10.1038/s41419-018-0802-8.

14.

The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment.

Marchiò C, Dell'Orto P, Annaratone L, Geyer FC, Venesio T, Berrino E, Verdun di Cantogno L, Garofoli A, Rangel N, Casorzo L, dell'Aglio C, Gugliotta P, Trisolini E, Beano A, Pietribiasi F, Orlassino R, Cassoni P, Pich A, Montemurro F, Mottolese M, Vincent-Salomon A, Penault-Llorca F, Medico E, Ng CKY, Viale G, Sapino A.

Am J Surg Pathol. 2018 Sep;42(9):1190-1200. doi: 10.1097/PAS.0000000000001100.

PMID:
29975246
15.

Predicting Late Fecal Incontinence Risk After Radiation Therapy for Prostate Cancer: New Insights From External Independent Validation.

Cicchetti A, Avuzzi B, Palorini F, Ballarini F, Stucchi C, Fellin G, Gabriele P, Vavassori V, Esposti CD, Cozzarini C, Fiorino C, Rancati T, Valdagni R.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):127-136. doi: 10.1016/j.ijrobp.2018.05.013. Epub 2018 Jun 30.

PMID:
29970313
16.

FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients.

Rangel N, Fortunati N, Osella-Abate S, Annaratone L, Isella C, Catalano MG, Rinella L, Metovic J, Boldorini R, Balmativola D, Ferrando P, Marano F, Cassoni P, Sapino A, Castellano I.

BMC Cancer. 2018 Jul 3;18(1):703. doi: 10.1186/s12885-018-4624-y.

17.

Preclinical models for precision oncology.

Ibarrola-Villava M, Cervantes A, Bardelli A.

Biochim Biophys Acta. 2018 Jun 28. pii: S0304-419X(18)30066-0. doi: 10.1016/j.bbcan.2018.06.004. [Epub ahead of print] Review.

PMID:
29959990
18.

Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.

Rizzolio S, Cagnoni G, Battistini C, Bonelli S, Isella C, Van Ginderachter JA, Bernards R, Di Nicolantonio F, Giordano S, Tamagnone L.

J Clin Invest. 2018 Aug 13. pii: 99257. doi: 10.1172/JCI99257. [Epub ahead of print]

19.

Next generation immune-checkpoints for cancer therapy.

Donini C, D'Ambrosio L, Grignani G, Aglietta M, Sangiolo D.

J Thorac Dis. 2018 May;10(Suppl 13):S1581-S1601. doi: 10.21037/jtd.2018.02.79. Review.

20.

Exploring the links between cancer and placenta development.

Costanzo V, Bardelli A, Siena S, Abrignani S.

Open Biol. 2018 Jun;8(6). pii: 180081. doi: 10.1098/rsob.180081.

Supplemental Content

Loading ...
Support Center